Antimicrobial resistance (AMR) is a global health crisis, projected to cause up to 10 million deaths annually and impose economic costs exceeding $150 billion by 2050.

In this Insights series, Around the World in HTAs, we shed light on HTA around the world. In this edition, Andrés ...

Analysis of Trump’s ‘Most Favoured Nation’ Executive Order on drug pricing, its global impact, price convergence aims, and ...

New OHE insight on immunisation: despite high returns on investment, global spending lags. We outline why and how countries ...

Pharmacogenomics (PGx) is the study of how genetic variation affects the efficacy and safety of medicines, enabling ...

Kiran Bhatti joined OHE in March 2025 as a Business Executive. She holds an MBA Master of Business Administration degree. She is a finance professional with over 18 years’ experience in business ...

Neil McAuslane PhD, MSc, BSc. Scientific Director of the Centre for Innovation in Regulatory Science (CIRS) overseeing the scientific content of both CIRS regulatory and HTA programmes. Key research ...

The UK is confronting a seismic demographic shift with an ageing population and declining fertility rates. In preparing for this change, it is critical that we shift how we think about health across ...